Gandeeva Therapeutics
PrivateLast Round
Series A
Jan 13, 2022
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gandeeva Therapeutics is a biotechnology company that leverages cryogenic electron microscopy and machine learning to develop novel therapeutics targeting protein-protein interactions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gandeeva Therapeutics Comparables
Compare Gandeeva Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 81% | |
| Iambic Therapeutics | 80% | |
| Health Technology Innovations, Inc. | 78% |
Gandeeva Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 13, 2022 |
Key People
Founding team and executive leadership
Gandeeva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Series A |
| Air Street Capital | Series A |
| Lux Capital | Series A |
| Obvious Ventures | Series A |
| Amgen Ventures | Series A |
| Leaps by Bayer | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 94% MoM, reaching 1.3K.
- Jan 13, 2022
$40M round led by Lux Capital and Leaps by Bayer.
Recent news
Latest coverage and updates
- partners_withJun 18, 2026
Gandeeva Therapeutics, Inc. partnered with Zymeworks Inc. on Jun 18th '26.
Gandeeva Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gandeeva Therapeutics's valuation, stock price, and market status.
Is Gandeeva a public or private company?
Gandeeva is a private company.
What is the current stock price of Gandeeva?
Gandeeva is a private company with no public stock price. No recent secondary market data is available.
How much is Gandeeva worth (valuation)?
Valuation information for Gandeeva is not publicly available.
Can I buy Gandeeva stock?
Gandeeva shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gandeeva's last funding round?
Gandeeva's most recent funding round was Series A on January 13, 2022.
Who are the main investors in Gandeeva?
Key investors in Gandeeva include Lux Capital, Leaps by Bayer.
Will Gandeeva IPO soon?
No public IPO plans have been announced for Gandeeva.
How can I track Gandeeva secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gandeeva's secondary market activity and sign up for updates.